Sfoglia per Autore
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
2017 Kieffer, J; Postma, T; van de Poll Franse, L; Mols, F; Heimans, J; Cavaletti, G; Aaronson, N; Cavaletti, G; Cornblath, D; Merkies, I; Postma, T; Valsecchi, M; Galimberti, S; Rossi, E; Cavaletti, G; Frigeni, B; Lanzani, F; Mattavelli, L; Piatti, M; Alberti, P; Binda, D; Bidoli, P; Cazzaniga, M; Cortinovis, D; Bruna, J; Velasco, R; Argyriou, A; Kalofonos, H; Psimaras, D; Ricard, D; Pace, A; Galiã¨, E; Briani, C; Lucchetta, M; Campagnolo, M; Torre, C; Faber, C; Merkies, I; Vanhoutte, E; Bakkers, M; Brouwer, B; Boogerd, M; Lalisang, R; Boogerd, W; Brandsma, D; Koeppen, S; Hense, J; Grant, R; Storey, D; Kerrigan, S; Schenone, A; Reni, L; Piras, B; Fabbri, S; Pessino, A; Padua, L; Granata, G; Leandri, M; Ghignotti, I; Plasmati, R; Pastorelli, F; Postma, T; Heimans, J; Eurelings, M; Meijer, R; Grisold, W; Pozza, E; Mazzeo, A; Toscano, A; Russo, M; Tomasello, C; Altavilla, G; Prado, M; Gonzalez, C; Dorsey, S
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial
2017 Ghi, M; Paccagnella, A; Ferrari, D; Foa, P; Alterio, D; Codecà, C; Nolè, F; Verri, E; Orecchia, R; Morelli, F; Parisi, S; Mastromauro, C; Mione, C; Rossetto, C; Polsinelli, M; Koussis, H; Loreggian, L; Bonetti, A; Campostrini, F; Azzarello, G; D'Ambrosio, C; Bertoni, F; Casanova, C; Emiliani, E; Guaraldi, M; Bunkheila, F; Bidoli, P; Niespolo, R; Gava, A; Massa, E; Frattegiani, A; Valduga, F; Pieri, G; Cipani, T; Da Corte, D; Chiappa, F; Rulli, E
Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX
2017 Emile, J; Julie, C; Le Malicot, K; Lepage, C; Tabernero, J; Mini, E; Folprecht, G; Van Laethem, J; Dimet, S; Boulagnon-Rombi, C; Allard, M; Penault-Llorca, F; Bennouna, J; Laurent-Puig, P; Taieb, J; Bidoli, P
Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift
2017 Fabbri, A; Cossa, M; Sonzogni, A; Bidoli, P; Canova, S; Cortinovis, D; Abbate, M; Calabrese, F; Nannini, N; Lunardi, F; Rossi, G; La Rosa, S; Capella, C; Tamborini, E; Perrone, F; Busico, A; Capone, I; Valeri, B; Pastorino, U; Albini, A; Pelosi, G
Comment on: "is there a role for Vitamin D in human reproduction?"
2017 Colonese, F; La Rosa, V; Laganà, A; Vitale, S; Cortinovis, D; Bidoli, P
Gemcitabine-induced thrombocytosis as a potential predictive factor in non-small cell lung cancer: Analysis of 318 patients
2017 Canova, S; Cicchiello, F; Agustoni, F; Bianchini, G; Abbate, M; Bidoli, P; Cortinovis, D
A new race against lung cancer
2017 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
EAGLES study: First-line bevacizumab in combination with chemotherapy in elderly patients with advanced, metastatic, non-squamous non-small cell lung cancer
2017 De Marinis, F; Bidoli, P; Luciani, A; Amoroso, D; Tonini, G; Bertolini, A; Brandes, A; Migliorino, M; Favaretto, A; Gridelli, C
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
2017 Bossi, P; Cortinovis, D; Fatigoni, S; Cossu Rocca, M; Fabi, A; Seminara, P; Ripamonti, C; Alfieri, S; Granata, R; Bergamini, C; Agustoni, F; Bidoli, P; Nolè, F; Pessi, M; Macchi, F; Michellini, L; Montanaro, F; Roila, F
Second-line erlotinib or intermittent erlotinib plus docetaxel in male ex-smokers with squamous NSCLC: The TALISMAN randomized trial
2016 Gridelli, C; Chella, A; Valmadre, G; Allegrini, G; Brighenti, M; Bidoli, P; Rossi, A; Maione, P; Migliorino, M; Ricciardi, S; De Marinis, F
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial
2016 Schuler, M; Yang, J; Park, K; Kim, J; Bennouna, J; Chen, Y; Chouaid, C; De Marinis, F; Feng, J; Grossi, F; Kim, D; Liu, X; Lu, S; Strausz, J; Vinnyk, Y; Wiewrodt, R; Zhou, C; Wang, B; Chand, V; Planchard, D; Bidoli, P
Focus on nivolumab in NSCLC
2016 Cortinovis, D; Canova, S; Abbate, M; Colonese, F; Bidoli, P
Corrigendum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer (British Journal of Cancer (2016) 115 (789-796) DOI: 10.1038/bjc.2016.271)
2016 Dalgleish, A; Stebbing, J; Adamson, D; Arif, S; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; Mcadam, K; Mcdermott, R; Martín, A; Papamichael, D; Pazo-Cid, R; Vieitez, J; Zaniboni, A; Carroll, K; Wagle, S; Gaya, A; Mudan, S
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
2016 Dalgleish, A; Stebbing, J; Adamson, D; Arif, S; Bidoli, P; Chang, D; Cheeseman, S; Diaz-Beveridge, R; Fernandez-Martos, C; Glynne-Jones, R; Granetto, C; Massuti, B; Mcadam, K; Mcdermott, R; Martín, A; Papamichael, D; Pazo-Cid, R; Vieitez, J; Zaniboni, A; Carroll, K; Wagle, S; Gaya, A; Mudan, S
Targeted therapies and immunotherapy in non-small-cell lung cancer
2016 Cortinovis, D; Abbate, M; Bidoli, P; Capici, S; Canova, S
Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer
2016 Cappuzzo, F; Morabito, A; Normanno, N; Bidoli, P; Del Conte, A; Giannetta, L; Montanino, A; Mazzoni, F; Buosi, R; Burgio, M; Cerea, G; Chiari, R; Cortinovis, D; Finocchiaro, G; Foltran, L; Migliorino, M; Tiseo, M; Ferrari, S; De Marinis, F
Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial
2016 Lonardi, S; Sobrero, A; Rosati, G; Di Bartolomeo, M; Ronzoni, M; Aprile, G; Scartozzi, M; Banzi, M; Zampino, M; Pasini, F; Marchetti, P; Cantore, M; Zaniboni, A; Rimassa, L; Ciuffreda, L; Ferrari, D; Barni, S; Zagonel, V; Maiello, E; Rulli, E; Labianca, R; Bidoli, P
Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc©) in patients with chemotherapy-induced peripheral neuropathy
2015 Binda, D; Cavaletti, G; Cornblath, D; Merkies, I; Valsecchi, M; Bidoli, P; Cortinovis, D
Isolated cardiac metastasis from squamous cell esophageal cancer
2015 Abbate, M; Cicchiello, F; Canova, S; Cortinovis, D; Mariani, S; Maffini, F; Bidoli, P
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
2015 Pivot, X; Manikhas, A; Żurawski, B; Chmielowska, E; Karaszewska, B; Allerton, R; Chan, S; Fabi, A; Bidoli, P; Gori, S; Ciruelos, E; Dank, M; Hornyak, L; Margolin, S; Nusch, A; Parikh, R; Nagi, F; Desilvio, M; Santillana, S; Swaby, R; Semiglazov, V
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile